Clinical Trials List
2022-04-15 - 2023-10-11
Phase I
Recruiting4
-
Trial Applicant
A2 HEALTHCARE TAIWAN CORPORATION
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chen-Yuan Lin Division of General Internal Medicine
- Ming-Yu Lien Division of General Internal Medicine
- Yu-Min Liao Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Muh-Hwa Yang Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃奕文 Digestive System Department
- Chao-Hua Chiu Digestive System Department
- Jia-Ruey Tsai Digestive System Department
- Chia-Yu Wu Digestive System Department
- Hsin-Lun Lee Digestive System Department
- MING-CHE LIU Digestive System Department
- Shih Hsin Tu Digestive System Department
- Huan-Tze Lin Digestive System Department
- Shih-Hsin Hsiao Digestive System Department
- Cheng-I Hsieh Digestive System Department
- Kai-Ling Lee Digestive System Department
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Cheng-Lung Hsu Division of Hematology & Oncology
- 徐執中 Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Mengting Peng Division of Hematology & Oncology
- 吳教恩 Division of Hematology & Oncology
- 余紹銘 Division of Hematology & Oncology
- 陳安欣 Division of Hematology & Oncology
- Hung-Ming Wang Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
- HSUAN JEN SHIH Division of Hematology & Oncology
- Chan-Keng Yang Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- Pei-Wei Huang Division of Hematology & Oncology
- 潘廣澤 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
50 participants
